Recent

% | $
Quotes you view appear here for quick access.

Chelsea Therapeutics Internatio Message Board

  • padil2050 padil2050 Feb 20, 2013 4:01 PM Flag

    prevent dizziness and falling in patients with Parkinson's disease.============ billions

     

    prevent dizziness and falling in patients with Parkinson's disease.============ billions

    This topic is deleted.
    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • tulsadevlin@sbcglobal.net tulsadevlin Feb 20, 2013 4:19 PM Flag

      the company still has over $28M in cash, enough to get to FDA approval and beyond. Despite the sharp run-up on Wednesday's news, we believe upside in CHTP is still significant, particularly, if the drug can be developed in other indications and achieve sales north of $50M annually. At ~$1.50 per share, and with new guidance from the FDA that currently-generated Phase III data could be enough for approval, we believe CHTP is a good bet.

      Sentiment: Hold

 
CHTP
6.520.00(0.00%)Jun 23 4:00 PMEDT